What is the appropriate age range for prescribing brompheniramine and pseudoephedrine (Bromfed) to children?

Appropriate Age for Prescribing Bromfed (Brompheniramine/Pseudoephedrine) in Children

Bromfed should generally be avoided in all children below 6 years of age due to safety concerns, lack of proven efficacy, and documented fatalities; for children 6 years and older, it may be prescribed with caution, though safer alternatives like second-generation antihistamines or intranasal corticosteroids should be strongly considered first.

Critical Safety Evidence

The most compelling evidence comes from FDA Adverse Event Reporting System data showing 9 fatalities associated with brompheniramine in children, with 41 deaths occurring below age 2 years when considering all first-generation antihistamines in combination products 1. The FDA drug label explicitly states that safety and effectiveness in pediatric patients below the age of 6 months have not been established 2.

Guideline-Based Age Restrictions

The 2008 Journal of Allergy and Clinical Immunology practice parameter provides the strongest guidance:

• Children under 6 years: These OTC cough and cold medications (including antihistamine-decongestant combinations like Bromfed) should be generally avoided due to:

  • Lack of established efficacy for upper respiratory infections 1
  • Potential toxicity and documented fatalities
  • Common overdose errors from multiple product use, medication errors, and accidental exposures

• FDA Advisory Committee Recommendation (2007): OTC medications used to treat cough and cold should no longer be used for children below 6 years of age 1

Age-Specific Prescribing Algorithm

Children Under 6 Years Old

• Do NOT prescribe Bromfed
• Consider second-generation antihistamines instead (cetirizine, loratadine, desloratadine, fexofenadine, levocetirizine), which have demonstrated excellent safety profiles in young children 1
• Consider intranasal corticosteroids as first-line therapy for allergic rhinitis 3

Children 6 Years and Older

• May prescribe with extreme caution 2
• Ensure proper dosing based on age and weight
• Warn caregivers about:
  • Not combining with other cough/cold products containing similar ingredients
  • Avoiding activities requiring mental alertness
  • Contraindications in patients with narrow-angle glaucoma, urinary retention, or bronchial asthma 2

Adolescents 15 Years and Older

• More appropriate age group for pseudoephedrine-containing products 4
• Still requires careful risk-benefit assessment
• Monitor for cardiovascular and neurological adverse events

Critical Safety Warnings

Common pitfalls to avoid:

1. Multiple product use: The majority of overdose deaths resulted from concurrent use of multiple cough/cold products 1

2. Extended duration: Pseudoephedrine should only be used temporarily, not for extended periods. Studies show 25% of users took it for >1 week, including young children at highest risk 5

3. Contraindications: Bromfed is absolutely contraindicated with MAO inhibitors and in nursing mothers 2

4. Higher risk populations: Children with diabetes, hypertension, heart disease, or thyroid disease require additional caution 2

Safer Alternative Recommendations

For children requiring treatment for allergic rhinitis or nasal congestion:

• First-line: Intranasal corticosteroids (most effective medication class) 3
• Second-line: Second-generation oral antihistamines (cetirizine, loratadine) with proven safety in children as young as 2 years 1
• Third-line: Intranasal antihistamines for children ≥5-6 years 3

The evidence strongly supports avoiding Bromfed in young children, with the 6-year age threshold representing the minimum safe prescribing age, though even then, safer alternatives should be prioritized.